Endoscopic and Biomarker Monitoring for Advanced Practice Providers
Endoscopic and biomarker monitoring for advanced practice providers with guidance on disease activity assessment and treatment response in I
Advanced practice providers have opportunities to utilize endoscopy and biomarker monitoring for monitoring IBD. IBD often requires providers to do more than symptomatic relays and therefore requires APPs to do endoscopy and biomarker monitoring as part of clinical workflows. Endoscopy and biomarker monitoring helps APPs to accurately assess disease activity and adjust treatment accordingly.
Endoscopy and biomarker monitoring helps implement strategies to reach and maintain remission. APPs can gain further confidence and knowledge about the progression of disease monitoring and treatment response through expert education, clinical resource, and networking provided by IBD Community Network.
Endoscopic and biomarker surveillance for advanced practice providers is aimed at assessing disease activity and response to treatment in the inflammatory bowel disease population. Integrating these monitoring tools into routine care, APPs will aid in adopting treat-to-target strategies and risk reducing strategies whilst maintaining remission.
With the help of specialized collaboration, educational materials, and professional connections through the IBD Community Network, Advanced Practice Providers (APPs) can implement comprehensive monitoring practices to improve patient outcomes over time.
